CEVA Logistics opens Singapore cold station adjacent to Changi Airport
CEVA Logistics opened its temperature-controlled airfreight station today adjacent to Singapore’s Changi International Airport, positioning Singapore as a strategic healthcare logistics hub for the Asia Pacific region.
September 8, 2021: CEVA Logistics opened its temperature-controlled airfreight station today adjacent to Singapore’s Changi International Airport, positioning Singapore as a strategic healthcare logistics hub for the Asia Pacific region.
“CEVA’s latest cold station lies within the Free Trade Zone of the Airport Logistics Park of Singapore, facilitating seamless regional distribution in the Association of Southeast Asian Nations (ASEAN) region and providing in-transit storage, value-add services and quick turnaround times for connecting to global markets,” reads the release.
CEVA’s growing network of cold stations is in direct service of its Temperature Sensitive Solution, a pharmaceutical logistics offering ensuring that temperature-sensitive shipments across ambient and chilled conditions are maintained in their optimal environments throughout shipment.
The CEVA Logistics temperature-controlled solution required capital investment in specialized airfreight facilities around the world, and with the support of its parent company, the CMA CGM Group, a world leader in shipping and logistics, CEVA remains committed to operating a network of more than 40 such airfreight stations by the end of 2021. Additional stations in Atlanta, Chicago, Frankfurt, Madrid, Budapest and Mumbai are scheduled to open in the coming months. In all, the stations will allow CEVA to not only service major healthcare gateways in regional markets, like Asia Pacific, but also to supply more than 1,450 healthcare trade lanes globally.
To meet the demands of healthcare and pharmaceutical customers, the new station is composed of two distinct areas dedicated to temperature management of shipments within the ranges of 15 to 25 degrees Celsius and 2 to 8 degrees Celsius. CEVA will continue to focus on the spectrum of products requiring a range of 2 to 8 degrees Celsius, including certain COVID-19 vaccines, although the company provides solutions for other products, including vaccines requiring lower temperatures throughout transport.
Additional solutions such as Controlant, an automated control tower workflow tool, and Validaide, a risk assessment tool on lane validations, will also be available for customers to ensure reliability and compliance. The Singapore location’s proximity to local seaports, combined with reefer container options, also allows customers to access more environmentally friendly ocean freight transportation.
The CEVA FORPATIENTS suite of healthcare logistics encompasses temperature sensitive solutions, pharma and biopharma, medical devices, consumer health, hospital and home care, as well as diagnostic and laboratory services. In healthcare and pharmaceutical markets, CEVA serves more than 500 healthcare and life science companies globally, more than 50 healthcare contract logistics operations worldwide and 20 of the top 30 medical device supply chains.
Elaine Low, managing director for Southeast Asia and Pacific, CEVA Logistics, said, “As CEVA’s first airfreight cold chain facility in Singapore, this is a timely investment for healthcare logistics. This air hub is now capable of supporting the regional distribution of vaccines and other pharmaceutical supplies that are critically needed in Southeast Asia at the moment. In addition, our healthcare customers will benefit from the range of value-added services, such as dry ice, relabelling and cross-stocking within the free trade zone.”
Says Niels van Namen, executive vice president of global healthcare, CEVA Logistics, said, “Our FORPATIENTS commitment is driving our investment in healthcare logistics. These airfreight cold chain stations are just one more example of how we put the patient first, even in the supply chain. We have the expertise and now another facility to continue supporting customers who require stringent temperature management within their global supply chains to ensure the integrity of their patients’ products.”